Newtyn Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Newtyn Management’s Portfolio PHAT Stock Details PHAT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$1.75M	Sell
2023 Q4	$5.9M	Buy
2023 Q3	$5.18M	Sell
2023 Q2	$9.79M	Buy
2023 Q1	$4.87M	Buy
2022 Q4	$5.43M	Buy
2022 Q3	$3.5M	Buy
2022 Q2	$2.16M	Buy